Artificial Pancreas Device System Market Outlook Assessing Future Opportunities And Growth Prospects
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Value Outlook For The Artificial Pancreas Device System Market Through 2030?
The artificial pancreas device system market size has experienced rapid expansion in recent years. It is anticipated to increase from $2.06 billion in 2025 to $2.35 billion in 2026, showing a compound annual growth rate (CAGR) of 13.9%. The market’s past growth can be ascribed to several factors, including the rising incidence of diabetes, the initial adoption of insulin pump technologies, the wider application of continuous glucose monitoring, advancements in the accuracy of medical sensors, and a heightened awareness of automated diabetes management.
The artificial pancreas device system market size is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $3.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. This projected growth is driven by several factors, including the escalating demand for fully automated glucose regulation, rising investments in digital diabetes care, the broadening scope of remote patient monitoring, a growing focus on personalized insulin therapy, and increasing regulatory support for advanced diabetes devices. Key trends anticipated during this period involve a wider uptake of closed-loop glucose control systems, the increasing integration of continuous glucose monitors (CGM) with insulin pumps, the evolving use of predictive algorithms for insulin delivery, the expansion of wearable diabetes management devices, and an enhanced commitment to patient-centric automation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
Which Significant Factors Are Encouraging Growth In The Artificial Pancreas Device System Market?
The increasing prevalence of pancreatic cancer is expected to propel the growth of the artificial pancreas device system market going forward. Pancreatic cancer is a malignant tumor that originates in the pancreas, a gland located behind the stomach. This condition is influenced by a combination of lifestyle, genetic, medical, and environmental factors, alongside genetic mutations leading to hereditary pancreatitis, which can cause chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to help individuals with diabetes manage their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For instance, in March 2024, Cancer Australia, a government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, an increase from the 3,751 cases reported over the past five years. Therefore, the increasing prevalence of pancreatic cancer is driving the growth of the artificial pancreas device system market.
How Is The Artificial Pancreas Device System Market Examined Through Segment Analysis?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
Which Trends Are Shaping The Artificial Pancreas Device System Market Landscape?
Leading entities within the artificial pancreas device system market are creating automated insulin delivery solutions to improve diabetes care through the automatic observation of blood glucose levels and dispensing of suitable insulin quantities. These automated systems seek to mimic a healthy pancreas’s function, thereby alleviating the continuous requirement for blood sugar checks and the manual self-administration of insulin for those living with diabetes. An example of this advancement occurred in May 2023, when Beta Bionics, a medical equipment manufacturer based in the US, secured FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, which is an automated insulin delivery apparatus. This particular system operates as an artificial pancreas, engineered to independently calculate and dispense insulin doses to manage blood glucose effectively. Functioning as a closed-loop mechanism, it automatically modifies insulin dispensation according to the user’s glucose readings, obtained from an integrated continuous glucose monitor (CGM). For automatic insulin delivery adjustments, it solely needs the user’s body weight and an estimation of meal size.
Who Are The Key Market Participants In The Artificial Pancreas Device System Market?
Major companies operating in the artificial pancreas device system market are Medtronic plc, Abbott Laboratories, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, Ypsomed, SOOIL Development, Beta Bionics Inc., Bigfoot Biomedical Inc., Diabeloop SA, Inreda Diabetic B.V., Defymed SAS, DreaMed Diabetes Ltd., Medtrum Technologies Inc., EOFlow Co. Ltd., Cellnovo, Pancreum Inc., Admetsys Corporation, GlucoModicum, MicroTech Medical
Access The Complete Artificial Pancreas Device System Market Report:
What Is The Largest Regional Market In The Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Pancreas Device System Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2026, By The Business Research Company
Diabetes Care Devices Market 2026
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market
Gastrointestinal Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Hepato Pancreatico Biliary Hpb Surgeries Surgical Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
